Switch to:
More From Other Websites
GlaxoSmithKline's Sideways Dance May Pay Off in the Long Run Jul 22 2016
GlaxoSmithKline Segments That Drive Company’s Rising Revenues Jul 22 2016
GSK’s HIV Products Expected to Have Driven 2Q Earnings Jul 22 2016
BioFlash podcast: Why Big Pharma is hungry for bacteria Jul 22 2016
Inside the Foreign Exchange Impact on Novartis’s Growth in 2Q16 Jul 21 2016
How Did Novartis’s 2Q16 Earnings Stand up to Analyst Estimates? Jul 21 2016
GSK ships 2016-17 seasonal influenza vaccines for US market Jul 20 2016
VBIV: A Differentiated Immunology Company With Multiple Near Term Value Drivers Jul 20 2016
Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
Your inhaler's watching you: drugmakers race for smart devices Jul 20 2016
Apple Goes After Enormous Medical Technology Market Jul 19 2016
Where GSK ranks in R&D spending against sales and marketing Jul 19 2016
Novartis in no rush to sell down stake on GSK consumer venture Jul 19 2016
Novartis in no rush to sell down stake on GSK consumer venture Jul 19 2016
Will GlaxoSmithKline plc and AstraZeneca plc continue to be Brexit winners? Jul 19 2016
The iPhone is being used to study rheumatoid arthritis Jul 18 2016
Why GlaxoSmithKline, Groupon, Lending Club And 2 Micro-Caps Are Trending Today Jul 18 2016
Why Novartis’s 2Q16 Revenues Are Expected to Fall Jul 18 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK